These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Immunoscintigraphy of lung cancer using 111In-labelled antiCEA F023C5-F(ab')2 fragments. Torres M, Jiménez-Heffernan A, Valverde A, González FM, Latre JM, Llamas JM, Baamonde C, López-Rubio F, Mateo A. Nucl Med Commun; 1991 Nov; 12(11):937-50. PubMed ID: 1661391 [Abstract] [Full Text] [Related]
12. The contribution of immunoscintigraphy to the diagnosis of head and neck tumours. De Rossi G, Maurizi M, Almadori G, Di Giuda D, Paludetti G, Cadoni G, Ottaviani F, Galli J. Nucl Med Commun; 1997 Jan; 18(1):10-6. PubMed ID: 9061695 [Abstract] [Full Text] [Related]
13. Immunoscintigraphy of small-cell lung cancer: a study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations. Macmillan CH, Perkins AC, Wastie ML, Leach IH, Morgan DA. Br J Cancer; 1993 Jun; 67(6):1391-4. PubMed ID: 8390288 [Abstract] [Full Text] [Related]
14. Imaging of pharyngeal and laryngeal carcinomas with indium-111-labeled monoclonal anti-CEA antibodies. Kairemo KJ, Hopsu EV. Laryngoscope; 1990 Oct; 100(10 Pt 1):1077-82. PubMed ID: 2215039 [Abstract] [Full Text] [Related]